Have a feature idea you'd love to see implemented?
Let us know!
STXS Stereotaxis Inc
Price (delayed)
$2.05
Market cap
$173.7M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.27
Enterprise value
$168.82M
Stereotaxis is the global leader in innovative robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. Its mission is the discovery, development and delivery of robotic
Highlights
STXS's revenue is down by 15% YoY but it is up by 6% from the previous quarter
STXS's quick ratio has shrunk by 58% YoY and by 38% QoQ
STXS's equity is down by 42% year-on-year and by 4.8% since the previous quarter
Key stats
What are the main financial stats of STXS
Market
Valuations
Earnings
Shares outstanding
84.73M
Market cap
$173.7M
Enterprise value
$168.82M
Price to earnings (P/E)
N/A
Price to book (P/B)
16.05
Price to sales (P/S)
7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.71
Revenue
$25.14M
EBIT
-$21.57M
EBITDA
-$20.81M
Free cash flow
-$12.23M
Per share
Balance sheet
Liquidity
EPS
-$0.27
Free cash flow per share
-$0.14
Book value per share
$0.13
Revenue per share
$0.29
TBVPS
$0.45
Total assets
$50.94M
Total liabilities
$34.71M
Debt
$6.14M
Equity
$10.82M
Working capital
$8.09M
Debt to equity
0.57
Current ratio
1.39
Quick ratio
0.91
Net debt/EBITDA
0.23
Margins
Efficiency
Dividend
EBITDA margin
-82.8%
Gross margin
56.1%
Net margin
-85.8%
Operating margin
-89.2%
Return on assets
-54.4%
Return on equity
-172.5%
Return on invested capital
-160.1%
Return on capital employed
-71.4%
Return on sales
-85.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
STXS stock price
How has the Stereotaxis stock price performed over time
Intraday
0.99%
1 week
-1.91%
1 month
4.59%
1 year
35.76%
YTD
17.14%
QTD
0.49%
Financial performance
How have Stereotaxis's revenue and profit performed over time
Revenue
$25.14M
Gross profit
$14.12M
Operating income
-$22.42M
Net income
-$21.57M
Gross margin
56.1%
Net margin
-85.8%
Stereotaxis's net margin has decreased by 28% YoY
STXS's operating margin is down by 25% YoY but it is up by 2.4% from the previous quarter
STXS's revenue is down by 15% YoY but it is up by 6% from the previous quarter
Stereotaxis's gross profit has decreased by 14% YoY
Growth
What is Stereotaxis's growth rate over time
Valuation
What is Stereotaxis stock price valuation
P/E
N/A
P/B
16.05
P/S
7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.71
The EPS has contracted by 3.8% from the previous quarter
STXS's P/B is 56% above its 5-year quarterly average of 10.3 and 22% above its last 4 quarters average of 13.2
STXS's equity is down by 42% year-on-year and by 4.8% since the previous quarter
The stock's price to sales (P/S) is 24% less than its 5-year quarterly average of 9.2 but 4.5% more than its last 4 quarters average of 6.7
STXS's revenue is down by 15% YoY but it is up by 6% from the previous quarter
Efficiency
How efficient is Stereotaxis business performance
STXS's return on invested capital has dropped by 103% year-on-year and by 7% since the previous quarter
Stereotaxis's return on equity has shrunk by 84% YoY and by 19% QoQ
The ROS has contracted by 28% YoY
Stereotaxis's ROA has decreased by 27% YoY
Dividends
What is STXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for STXS.
Financial health
How did Stereotaxis financials performed over time
The company's total assets is 47% higher than its total liabilities
STXS's total liabilities has soared by 80% from the previous quarter and by 72% YoY
STXS's quick ratio has shrunk by 58% YoY and by 38% QoQ
Stereotaxis's debt is 43% less than its equity
STXS's debt to equity has soared by 90% year-on-year and by 21% since the previous quarter
STXS's equity is down by 42% year-on-year and by 4.8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.